121 related articles for article (PubMed ID: 36648607)
1. LINC02381 suppresses cell proliferation and promotes apoptosis via attenuating IGF1R/PI3K/AKT signaling pathway in breast cancer.
Golestan S; Soltani BM; Jafarzadeh M; Ghaemi Z; Nafisi N
Funct Integr Genomics; 2023 Jan; 23(1):40. PubMed ID: 36648607
[TBL] [Abstract][Full Text] [Related]
2. LINC02381-ceRNA exerts its oncogenic effect through regulation of IGF1R signaling pathway in glioma.
Nemati H; Fakhre-Taha M; Javanmard AR; Jahanbakhshi A; Mowla SJ; Soltani BM
J Neurooncol; 2022 May; 158(1):1-13. PubMed ID: 35460500
[TBL] [Abstract][Full Text] [Related]
3. Novel splice variants of LINC00963 suppress colorectal cancer cell proliferation via miR-10a/miR-143/miR-217/miR-512-mediated regulation of PI3K/AKT and Wnt/β-catenin signaling pathways.
Ghaemi Z; Mowla SJ; Soltani BM
Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194921. PubMed ID: 36804476
[TBL] [Abstract][Full Text] [Related]
4. Epigenetically silenced LINC02381 functions as a tumor suppressor by regulating PI3K-Akt signaling pathway.
Jafarzadeh M; Soltani BM; Soleimani M; Hosseinkhani S
Biochimie; 2020; 171-172():63-71. PubMed ID: 32092325
[TBL] [Abstract][Full Text] [Related]
5. miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R.
Guo F; Zhu X; Zhao Q; Huang Q
Int J Mol Med; 2020 Sep; 46(3):989-1002. PubMed ID: 32705168
[TBL] [Abstract][Full Text] [Related]
6. LINC02381 aggravates breast cancer through the miR-1271-5p/FN1 axis to activate PI3K/AKT pathway.
Huang S; Huang P; Wu H; Wang S; Liu G
Mol Carcinog; 2022 Mar; 61(3):346-358. PubMed ID: 34882856
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA ncRuPAR regulates gastric cancer cell proliferation and apoptosis via phosphoinositide 3-kinase/protein kinase B signaling.
Xu R; Yu J; Song S; Sun D; Xiu L; Xu J; Zhao J; Liu X; Ji Q; Yue X
Int J Med Sci; 2022; 19(13):1835-1846. PubMed ID: 36438913
[No Abstract] [Full Text] [Related]
9. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway.
Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX
J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA KB-1980E6.3 promotes breast cancer progression through the PI3K/AKT signalling pathway.
He L; Tang L; Wang R; Liu L; Zhu P; Jiang K; Tu G
Pathol Res Pract; 2022 Jun; 234():153891. PubMed ID: 35461041
[TBL] [Abstract][Full Text] [Related]
12. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of LINC00619 promotes apoptosis and inhibits proliferation, migration and invasion while promoting apoptosis of osteosarcoma cells through inactivation of the HGF-mediated PI3K-Akt signalling pathway.
Zi X; Zhang G; Qiu S
Epigenetics; 2022; 17(2):147-160. PubMed ID: 33797312
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
[TBL] [Abstract][Full Text] [Related]
15. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
Lu D; Sun L; Li Z; Mu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
[TBL] [Abstract][Full Text] [Related]
16. Cell specific tumor suppressor effect of Hsa-miR-1226-3p through downregulation of HER2, PIK3R2, and AKT1 genes.
Mohamadzade Z; M Soltani B; Ghaemi Z; Hoseinpour P
Int J Biochem Cell Biol; 2021 May; 134():105965. PubMed ID: 33675995
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
18. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R.
Yang C; Xia Z; Zhu L; Li Y; Zheng Z; Liang J; Wu L
Cell Cycle; 2019 Dec; 18(24):3513-3524. PubMed ID: 31724454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
